Clinical Trial Update: Omega-3 Long Chain Polyunsaturated Fatty Acid (LCPUFA) Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of Prematurity [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating omega-3 long-chain polyunsaturated fatty acid supplementation to prevent retinopathy of prematurity in very low birth weight infants; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Drugs mentioned

• Omega-3 long chain polyunsaturated fatty acid supplementation (omega-3 long-chain polyunsaturated fatty acids)

Snippet

Sponsor: University of California, San Diego | Conditions: Retinopathy of Prematurity | Phase 2 | Status: COMPLETED | Results posted: 2022-12-29